Back to AZN
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
View Full LandscapeDrug Information
Target Indication
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Clinical Trial
NCT02104817Last updated: 2/9/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts